The Executive Committee of the ECOG-ACRIN Cancer Research Group is one of two committees that govern the Group under the leadership of the Group Co-Chairs (the other is the Principal Investigator Committee). The Executive Committee monitors the scientific and operational progress of the Group by approving research concepts and overseeing strategic planning, finances, resource allocation, and related matters. The committee also frequently recommends topics to include on agendas for PI Committee meetings, and resolves organizational issues that may arise from time to time.

The Executive Committee consists of the Executive Leadership, individuals elected by the Principal Investigator (PI) Committee, and individuals appointed by the Group Co-Chairs to represent the interests of defined constituent groups. Examples of constituent groups are translational scientists, cancer research advocates, underserved populations, and clinical trial professionals. The committee meets quarterly. All members of the Executive Committee have voting status.

The following 22 individuals, stratified by category (ie, executive, elected, and appointed members), are the current members of the Executive Committee.

ECOG-ACRIN Executive Committee Roster

Executive Members

Group Co-Chair
Peter J. O’Dwyer, MD
University of Pennsylvania and the Abramson Cancer Center
Mitchell D. Schnall, MD, PhD
Group Co-Chair
Mitchell D. Schnall, MD, PhD
University of Pennsylvania
Constantine A. Gatsonis, PhD
Group Statistician
Constantine A. Gatsonis, PhD
Brown University
Robert J. Gray, PhD
Group Statistician
Robert J. Gray, PhD
Dana-Farber Cancer Institute
Joseph A. Sparano, MD
Vice Chair
Joseph A. Sparano, MD
Montefiore Minority/Underserved NCORP
Bruce J. Giantonio, MD, FACP
Executive Officer
Bruce J. Giantonio, MD, FACP
Harvard Medical School and Massachusetts General Hospital
Donna M. Marinucci
Executive Director
Donna M. Marinucci, BSMT
Drexel University

Elected Members

Barry A. Siegel, MD
Barry A. Siegel, MD
Washington University in St. Louis
brad-s-kahl
Heather A. Wakelee, MD
Stanford University and the Stanford Cancer Institute
Kurt R. Oettel, MD
Kurt R. Oettel, MD
Wisconsin NCORP
Gundersen Lutheran Health System
Gary I. Cohen, MD
Gary I. Cohen, MD
Greater Baltimore Medical Center, an affiliate of The Sidney Kimmel Comprehensive Cancer Center of Johns Hopkins University

Appointed Members

 

Lynne Wagner
Deputy Chair, Cancer Control and Outcomes Program
Lynne I. Wagner, PhD
Wake Forest University and the Comprehensive Cancer Center of Wake Forest University
Suresh S. Ramalingam, MD
Deputy Chair, Therapeutic Studies Program
Suresh S. Ramalingam, MD
Emory University and the Winship Cancer Institute
 Keith T. Flaherty, MD
Deputy Chair, Biomarker Sciences Program
Keith T. Flaherty, MD
Massachusetts General Hospital Cancer Center
Stanley R. Hamilton, MD
Deputy Chair, Laboratory Sciences
Stanley R. Hamilton, MD
The University of Texas and the MD Anderson Cancer Center

 

Joseph Aisner, MD
Joseph Aisner, MD
Rutgers Cancer Institute of New Jersey
Michael A. Carducci, MD, FACP
Michael A. Carducci, MD, FACP
Johns Hopkins University and The Sidney Kimmel Comprehensive Cancer Center
George W. Sledge Jr, MD
George W. Sledge Jr., MD
Stanford University and the Stanford Cancer Institute
Mary Lou Smith, JD, MBA
Mary Lou Smith, JD, MBA
Research Advocacy Network
Edith P. Mitchell, MD, FACP
Edith P. Mitchell, MD, FACP
Thomas Jefferson University and the Sidney Kimmel Cancer Center at Thomas Jefferson University
Wendy J. Smith, BS, RTRCV, CCRP
Wendy J. Smith, BS, RTRCV, CCRP
Rhode Island Hospital

Contact

Direct inquiries about this committee to:

Jean MacDonald, MPH
Deputy Director, Operations
ECOG-ACRIN Cancer Research Group
Phone: 857.504.2900
Email

Return to Top | Return to Governance